Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vascular Surgery

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    November 2016
  1. HERZEELE IV, Vermassen F
    Selection, technique, and follow-up: keys to success in EVAR.
    Lancet. 2016;388:2326-2328.
    PubMed     Text format    


  2. PATEL R, Sweeting MJ, Powell JT, Greenhalgh RM, et al
    Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.
    Lancet. 2016;388:2366-2374.
    PubMed     Text format     Abstract available


  3. GEORGE J
    Antibiotic-impregnated catheters for prevention of bloodstream infection.
    Lancet. 2016;388:2235.
    PubMed     Text format    


  4. GILBERT RE, Mok Q, Millar M, Blundell M, et al
    Antibiotic-impregnated catheters for prevention of bloodstream infection - Authors' reply.
    Lancet. 2016;388:2235-2236.
    PubMed     Text format    


    October 2016
  5. FINN AV, Virmani R
    Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32063.
    PubMed     Text format    


  6. MACK M, Holmes DR
    Randomised trials in left main disease: a NOBLE effort.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32067.
    PubMed     Text format    


  7. VON BIRGELEN C, Kok MM, van der Heijden LC, Danse PW, et al
    Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31920.
    PubMed     Text format     Abstract available


  8. ALI ZA, Maehara A, Genereux P, Shlofmitz RA, et al
    Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31922.
    PubMed     Text format     Abstract available


  9. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available


  10. ISAAZ K, Gerbay A
    Deferred stenting in acute ST elevation myocardial infarction.
    Lancet. 2016;388:1371.
    PubMed     Text format    


  11. KELBAEK H, Hofsten DE, Engstrom T, Helqvist S, et al
    Deferred stenting in acute ST elevation myocardial infarction - Authors' reply.
    Lancet. 2016;388:1371-1372.
    PubMed     Text format    


    August 2016
  12. CAYLA G, Cuisset T, Silvain J, Leclercq F, et al
    Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31323.
    PubMed     Text format     Abstract available


  13. WEINTRAUB WS
    Invasive management of acute coronary syndromes.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31273.
    PubMed     Text format    


  14. DALE A, Drysdale H, Heneghan C
    The CHAMPION trial outcomes were not adequately prespecified.
    Lancet. 2016;388:564.
    PubMed     Text format    


  15. REED GW, Rossi JE, Cannon CP
    Acute myocardial infarction.
    Lancet. 2016 Aug 5. pii: S0140-6736(16)30677.
    PubMed     Text format     Abstract available


  16. AITKEN E, Jackson A, Kearns R, Steven M, et al
    Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial.
    Lancet. 2016 Aug 1. pii: S0140-6736(16)30948.
    PubMed     Text format     Abstract available


  17. MAMODE N, Calder F
    Improving outcomes in dialysis fistulae.
    Lancet. 2016 Aug 1. pii: S0140-6736(16)31230.
    PubMed     Text format    


    June 2016
  18. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive strategy in acute coronary syndrome - Authors' reply.
    Lancet. 2016;387:2504.
    PubMed     Text format    


  19. MATHEW ST, Pakala AV, Thadani U
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503-4.
    PubMed     Text format    


  20. SHAH R
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    


  21. TIMMIS A
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    


  22. DALE A, Slade E, Heneghan C
    Outcomes reporting of the FAME trial.
    Lancet. 2016;387:2292.
    PubMed     Text format    


    April 2016
  23. GILBERT RE, Mok Q, Dwan K, Harron K, et al
    Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Lancet. 2016;387:1732-42.
    PubMed     Text format     Abstract available


  24. SLADE E, Hartley P, Heneghan C
    REGULATE-PCI trial.
    Lancet. 2016;387:1510.
    PubMed     Text format    


  25. LINCOFF AM, Alexander JH, Mehran R
    REGULATE-PCI trial--Author's reply.
    Lancet. 2016;387:1510-1.
    PubMed     Text format    


  26. VAN 'T HOF AW, Ottervanger JP
    Primary angioplasty for STEMI: hard to improve upon.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30123.
    PubMed     Text format    


  27. KELBAEK H, Hofsten DE, Kober L, Helqvist S, et al
    Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30072.
    PubMed     Text format     Abstract available


    March 2016
  28. NAYLOR AR
    Age and carotid intervention outcomes.
    Lancet. 2016;387:1255-7.
    PubMed     Text format    


    February 2016
  29. MUIR KW, White P
    HERMES: messenger for stroke interventional treatment.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00351.
    PubMed     Text format    


  30. GOYAL M, Menon BK, van Zwam WH, Dippel DW, et al
    Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00163.
    PubMed     Text format     Abstract available


  31. HOWARD G, Roubin GS, Jansen O, Hendrikse J, et al
    Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials.
    Lancet. 2016 Feb 12. pii: S0140-6736(15)01309.
    PubMed     Text format     Abstract available


  32. CASSESE S, Byrne RA, Ndrepepa G, Kufner S, et al
    Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
    Lancet. 2016;387:537-44.
    PubMed     Text format     Abstract available


    January 2016
  33. VERHEUGT FW
    An anticoagulant too good to be true for revascularisation.
    Lancet. 2016;387:314-5.
    PubMed     Text format    


  34. PSALTIS PJ, Nicholls SJ
    Management of acute coronary syndrome in the very elderly.
    Lancet. 2016 Jan 12. pii: S0140-6736(16)00036.
    PubMed     Text format    


  35. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Lancet. 2016 Jan 12. pii: S0140-6736(15)01166.
    PubMed     Text format     Abstract available


  36. FROBERT O, James SK
    Coronary thrombus aspiration: a lesson for clinical medicine.
    Lancet. 2016;387:97-8.
    PubMed     Text format    


    December 2015
  37. VALGIMIGLI M, Gargiullo G, Juni P
    Radial versus femoral access for cardiac catheterisation - Authors' reply.
    Lancet. 2015;386:2394.
    PubMed     Text format    


  38. BRIEGER D, Yong A
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2393-4.
    PubMed     Text format    


  39. SHAH R, Gardner JD
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392-3.
    PubMed     Text format    


  40. DOWLING C, Rao S, Kerr N, Muller D, et al
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392.
    PubMed     Text format    


    November 2015
  41. DELEWI R, Piek JJ
    Cardiac catheterisation: radiation for radialists.
    Lancet. 2015;386:2123-4.
    PubMed     Text format    


  42. LOBO MD, Sobotka PA, Dolan E, Witkowski A, et al
    Central arteriovenous anastomosis and hypertension - Authors' reply.
    Lancet. 2015;386:1821-2.
    PubMed     Text format    


  43. DEINUM J, Wetzels JF
    Central arteriovenous anastomosis and hypertension.
    Lancet. 2015;386:1821.
    PubMed     Text format    


  44. LINCOFF AM, Mehran R, Povsic TJ, Zelenkofske SL, et al
    Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00515.
    PubMed     Text format     Abstract available


    October 2015
  45. HEAD SJ, Kappetein AP
    Coronary artery disease: a dam in the river for ranolazine.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00458.
    PubMed     Text format    


  46. JOLLY SS, Cairns JA, Yusuf S, Rokoss MJ, et al
    Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00448.
    PubMed     Text format     Abstract available


  47. WEISZ G, Genereux P, Iniguez A, Zurakowski A, et al
    Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00459.
    PubMed     Text format     Abstract available


  48. HAUDE M, Ince H, Abizaid A, Toelg R, et al
    Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
    Lancet. 2015 Oct 9. pii: S0140-6736(15)00447.
    PubMed     Text format     Abstract available


    September 2015
  49. PLOURDE G, Pancholy SB, Nolan J, Jolly S, et al
    Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2015 Sep 24. pii: S0140-6736(15)00305.
    PubMed     Text format     Abstract available


  50. MIMOZ O, Lucet JC, Kerforne T, Pascal J, et al
    Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial tr
    Lancet. 2015 Sep 17. pii: S0140-6736(15)00244.
    PubMed     Text format     Abstract available


    August 2015
  51. SEDLIS SP, Lorin JD
    Percutaneous coronary intervention: FAME is lasting.
    Lancet. 2015 Aug 28. pii: S0140-6736(15)00044.
    PubMed     Text format    


  52. VAN NUNEN LX, Zimmermann FM, Tonino PA, Barbato E, et al
    Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
    Lancet. 2015 Aug 28. pii: S0140-6736(15)00057.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: